Detection of social frailty in older adults: validation and reliability of the Makizako Social Frailty Index for Turkish older adults, a cross-sectional study Authors: Cansu Atbas, Huseyin Sayin, Didem Karaduman, Zeynep Sahiner, Merve Hafizoglu, Murat Pehlivan, Cafer Balci, Burcu Balam Dogu, Meltem Halil, Mustafa Cankurtaran Published: 2025 ABSTRACT AbstractBackgroundAcknowledging social frailty is crucial in nations where the number of older adults is rising. This study aims to assess the validity and reliability of the Makizako Social Frailty Index among the Turkish older adult population.MethodsOne hundred and seventy patients were included in the study. Older adults admitted to the geriatric medicine outpatient clinic at the university hospital were included. All patients had a comprehensive geriatric assessment. The Edmonton Frail Scale (EFS) concordance test was used to assess the validity of the Makizako Social Frailty Index. Test-retest and inter-rater reliability analyses were also performed.ResultsThe mean age of the participants was 72.8 ± 5.82 years. Among them, 105 individuals (61.8%) were female. A total of 32 participants (18.8%) were living alone. There were 102 individuals (60.0%) with an educational duration of 5 years or less. There was a moderate concordance between the Makizako Social Frailty Index and the EFS (Cohen's kappa: 0.287, p<0.001). The Makizako Social Frailty Index inter-rater and retest reliabilities were excellent (Cohen's kappa: 0.913, p<0.001 and 0.895, p<0.001, respectively). The sensitivity of the Makizako Social Frailty Index determined according to the EFS was 68.00% (95%CI: 46.50-85.05), the specificity was 74.48% (95%CI: 66.58-81.35), the positive predictive value was 31.48% (95%CI: 23.78-40.35), and the negative predictive value was 93.10% (95%CI: 88.32-96.02).ConclusionsThe Makizako Social Frailty Index, which comprehensively assessed social frailty through five items, was a valid and reliable tool for the Turkish older adult population.Keywords: Frailty, Social frailty, Older adults, Geriatrics, Loneliness Introduction Frailty is a clinical state characterized by a decrease in an individual’s physiological reserves, leading to an increased susceptibility to internal and external stressors [1]. Heightened vulnerability raises the risk of unfavorable health outcomes [1]. Frailty is generally assessed through physical frailty, which refers to the inability to perform daily life activities independently or the prelude to this condition [2]. It is crucial to note that when assessing frailty, a comprehensive approach, including physical, psychological, and social components, is essential [3]. All of these components should be considered to ensure an accurate frailty analysis. Social frailty, one of the components of frailty, has received the least research attention among these domains [4]. The social component of frailty can be defined as the inability to meet one or more essential social needs throughout life and the risk of not meeting them [4]. Social frailty can lead to significant outcomes, such as a reduction in an individual’s capacity for self-care, higher occurrences of depression, and an elevated likelihood of mortality [5]. The Makizako Social Frailty Index comprises five components. It stands as one of the most extensively employed approaches for appraising social frailty in the older adult population. It has garnered recognition for its convenience and efficiency in assessing social frailty. Individuals are categorized into socially frail, pre-frail, and robust groups [6]. In countries where the older adult population is steadily increasing, the importance of recognizing older adults living with frailty becomes increasingly evident. It is also essential to evaluate their subcomponents. Frailty scales are primarily designed to identify physical frailty. However, the significance of identifying social frailty has grown with the evolving global landscape. The characteristics of social frailty are the absence of vital social resources, participation in social activities, and the inability to exercise self-management skills necessary for fulfilling basic social needs [7]. Therefore, there is a need for easily applicable, valid, and reliable screening tools to recognize social frailty. There is no valid and reliable social frailty scale in Turkish that we know of. This study aimed to assess the reliability and validity of the Makizako Social Frailty Index among Turkish older adults. Materials and methods Participants Patients aged 65 years and older who applied to the geriatric medicine outpatient clinic in a tertiary university hospital between June 2022 and April 2023 were included in the study. Inclusion criteria were agreeing to participate in the study and having the cognitive capacity to understand and answer the questions asked. Acute infection, acute illness (decompensated congestive heart failure, recent myocardial infarction/stroke, exacerbation of COPD, uncontrolled hyper-or hypothyroidism), active cancer and history of cancer, incapacity to provide a history, unwillingness to cooperate, moderate to advanced dementia, and major depression were exclusion criterias. All patients had a comprehensive geriatric assessment. Basic activities of daily living (ADLs) and instrumental activities of daily living (IADLs) are validated scales commonly employed to assess patients’ independence and functional capacity. The basic ADL scale includes six activities: bathing, dressing, toileting, continence, transferring, and feeding. The IADL scale encompasses using the phone, shopping, food preparation, housekeeping, laundry, transportation, managing medications, and handling finances. Patient scores for both basic ADLs (scored from 0 to 6 points) and IADLs (scored from 0 to 8 points) were documented [8, 9]. Nutritional status was assessed using the Mini Nutritional Assessment– Short Form (MNA-SF) (scored from 0 to 14 points). As the score decreases, the risk of malnutrition increases [10]. Cognitive function was evaluated using the Standardized Mini- Mental State Examination (S-MMSE) [11]. Demographic characteristics, chronic diseases, and medications were recorded. Study tool The Makizako Social Frailty Index, which was developed by Makizako et al. in 2015 [12], is being used for assessing social frailty in older adults. The tool consists of questions like: (1) “Do you go out less frequently compared with last year?“; (2) “Do you sometimes visit your friends?“; (3) “Do you feel you are helpful to friends or family?“; 4) “Do you live alone?“; and 5) “Do you talk with someone daily?“. “Yes” answers to questions 1 and 4 and “No” answers to questions 2, 3, and 5 were considered negative responses. According to the total number of negative responses, individuals were classified as living with robust if the score was 0, living with social prefrailty if the score was 1, and living with social frailty if the score was 2–5, according to predetermined cut-off points. Some patients were retested for reliability with a second assessment by the same physician two weeks after the initial assessment with the Makizako Social Frailty Index questionnaire. To test inter-rater reliability, another physician asked the questions to twenty patients in another room on the same day, sequentially but randomly. Physicians with five or more years of geriatric clinical experience performed it. Translation Translation and cultural adaptation were performed according to the recommendations of the ISPOR Working Group [13]. To validate the language, the Makizako Social Frailty Index was first translated from English to Turkish by native Turkish-speaking physicians who are translation experts and fluent in English. All authors agreed on the Turkish translation. After the translation check, the Turkish version of the test was translated back into English by two native English-speaking physicians who were unfamiliar with the original. Thus, language validation was performed with the “forward-backward translation” method. Finally, the test was performed by doctors on older adults living in the community to assess cultural adaptation. Reference tools The validity and reliability of the Edmonton Frail Scale was established in 2006 by Darryl B. Rolfson et al. at the University of Alberta, Canada [14]. It consists of nine domains of frailty that are recognized as determinants of frailty in the comprehensive geriatric assessment: cognition, general health status, functional independence, social support, medication use, nutrition, mood, continence, and self-reported functional performance. Among these frailty domains, general health status and drug use are measured with two questions, while the other domains are measured with a single question. The total assessment consists of 11 items. Individuals score between 0 and 17, with the increasing score correlating with how severe the frailty is [14]. The EFS frailty level scoring has five levels. It is classified as 0–4, no frailty; 5–6, apparently vulnerable; 7–8, mild frailty; 9–10, moderate frailty; 11 or more, severe frailty [14, 15]. Turkish validity and reliability study was conducted by Hülya Eskiizmirli Aygör et al. [16]. Ethical approval The study protocol was approved by the local ethics committee of Hacettepe University Faculty of Medicine (project number: GO 22/538, decision number:2022/09–60). Informed consent was obtained from all individual participants, and all procedures performed in studies involving human participants were by the ethical standards of the institutional and/or national research committee and the 1964 Declaration of Helsinki and subsequent amendments or comparable ethical standards. Statistical analysis The determination of the sample size was conducted by applying the two-rater kappa statistics method [17] by providing 90% power to determine the correct kappa when two categories according to the EFS robust and prefrail/frail frequencies in Turkey [16] were 0.42 and 0.58, respectively. The significance level used for this calculation was set to 0.05. The statistical analysis was performed using SPSS 25.0 (IBM, Armonk, NY, ABD). Categorical variables were represented in terms of counts and percentages. In contrast, continuous variables were expressed as either the mean and standard deviation or the median and interquartile range, contingent upon the normality of their distribution. The EFS was employed as the reference instrument to assess the construct validity of the Makizako Social Frailty Index. Cohen's kappa statistic was utilized to gauge the level of agreement in the assessment between the robust and frail categories when examining the concordance between the EFS and the Makizako Social Frailty Index. Cohen's kappa was also applied to investigate inter-rater and retest reliabilities. Sensitivity, specificity, positive predictive value, and negative predictive value were computed as part of the analysis. Data that were not normally distributed were compared between two groups using the Mann-Whitney-U test. A p-value less than 0.05 was considered to be statistically significant. Results A total of 170 patients were included in the study. The mean age of the participants was 72.8 ± 5.82 years. Among them, 105 individuals (61.8%) were female. A total of 32 participants (18.8%) were living alone. There were 102 individuals (60.0%) with an educational duration of 5 years or less. Additionally, 108 individuals (63.5%) were married. The demographic and clinical characteristics of the patients are presented in Table 1. Table 2 compares the demographic and clinical characteristics between living with social robust/prefrailty individuals and those living with social frailty according to the Makizako Social Frailty Index. Table 3 shows the correlation between the tests used in the comprehensive geriatric assessment and the Makizako Social FrailtyIndex, and concordance results between the Makizako Social Frailty Index and the reference test are shown in Table 4. v Table 1Demographic and clinical characteristics of patientsn = 170 (%)Characteristics Age (mean, SD)72.80±5.82 Sex (female)105 (61.8%) Educational duration ≤ 5 years102 (60.0%) Marital Status (married)108 (63.5%) Living Alone32 (18.8%)Comprehensive geriatric assessment-geriatric syndromes Dementia14 (8.2%) Depression23 (13.5%) Type 2 Diabetes Mellitus78 (45.9%) Hypertension129 (75.9%) Hyperlipidemia81 (47.6%) Coronary Artery Disease (CAD)50 (29.4%) Asthma12 (7.1%) Chronic Obstructive Pulmonary Disease (COPD)14 (8.2%) Polypharmacy*99 (58.2%) Number of Medications (median, IQR)5 [3–7] Urinary Incontinence75 (44.1%) Fall47 (27.6%) Weight Loss**29 (17.1%)n number, SD Standard deviation, IQR Interquartile range [25–75]*Polypharmacy was defined as using ≥ 5 medications**Weight loss was defined as ≥ 10% loss of total body weight in the past six months Demographic and clinical characteristics of patients n number, SD Standard deviation, IQR Interquartile range [25–75] *Polypharmacy was defined as using ≥ 5 medications **Weight loss was defined as ≥ 10% loss of total body weight in the past six months Table 2Comparison of demographic and clinical characteristics between robust/prefrail individuals and individuals living with social frailty according to the Makizako Social Frailty IndexRobust/Prefrail(n:116, 68.2%)Living with Social Frailty(n:54, 31.8%)p valueCharacteristics Age (mean, SD)72.25±5.2574.54±6.650.05 Sex (female)69 (59.48%)36 (66.67%)0.37 Sex (male)47 (40.52%)18 (33.33%) Educational duration ≤ 5 years69 (59.48%)33 (61.11%)0.84 Marital Status (married)81 (69.83%)27 (50.00%)0.01 Living Alone14 (12.1%)18 (33.3%)0.001Comprehensive geriatric assessment-geriatric syndromes Dementia10 (8.62%)4 (7.41%)0.79 Depression16 (13.80%)7 (13.00%)0.88 Type 2 Diabetes Mellitus53 (45.70%)25 (46.30%)0.94 Hypertension85 (73.30%)44 (81.50%)0.25 Hyperlipidemia55 (47.41%)26 (48.14%)0.93 Coronary Artery Disease (CAD)34 (29.31%)16 (29.63%)0.97 Asthma5 (4.30%)7 (13.00%)0.04 Chronic Obstructive Pulmonary Disease (COPD)7 (6.00%)7 (13.00%)0.13Polypharmacy*62 (53.45%)37 (68.52%)0.06Number of Medications [[median, min-max][IQR]5 [0–15)[3–7]6 (1–16)[4–8.25.25]0.03Urinary Incontinence44 (37.93%)31 (57.41%)0.02Fall27 (23.28%)20 (37.04%)0.06Weight Loss**19 (16.37%)10 (18.52%)0.73ADLs***[median, min-max][IQR]6 (2–6)[5–6]5 (3–6)[5–6]0.002IADLs***[median, min-max][IQR]8 (0–8)[8–8]8 (1–8)[6–8]0.004S-MMSE***[median, min-max][IQR]28 (12–30)[27–30]28 (11–30)[25–29]0.038MNA-SF***[median, min-max][IQR]14 (7–14)[12–14]13 (7–14)[11–14]0.004SARC-F***[median, min-max][IQR]1 (0–9)[0–2]4 (0–8)[0–4]< 0.001n number, SD Standard deviation, IQR Interquartile range [25–75]*Polypharmacy was defined as using ≥ 5 medications**Weight loss was defined as ≥ 10% loss of total body weight in the past six months***ADLs Activities of Daily Living, IADLs The Instrumental Activities of Daily Living, S-MMSE Standardized Mini Mental State Examination, GDS Geriatric depression scale, MNA-SF Mini Nutritional Assessment-Short Form, SARC-F The Strength, Assistance in walking, Rise from a chair, Climb stairs, Falls Comparison of demographic and clinical characteristics between robust/prefrail individuals and individuals living with social frailty according to the Makizako Social Frailty Index Number of Medications [[median, min-max] [IQR] 5 [0–15) [3–7] 6 (1–16) [4–8.25.25] ADLs*** [median, min-max] [IQR] 6 (2–6) [5–6] 5 (3–6) [5–6] IADLs*** [median, min-max] [IQR] 8 (0–8) [8–8] 8 (1–8) [6–8] S-MMSE*** [median, min-max] [IQR] 28 (12–30) [27–30] 28 (11–30) [25–29] MNA-SF*** [median, min-max] [IQR] 14 (7–14) [12–14] 13 (7–14) [11–14] SARC-F*** [median, min-max] [IQR] 1 (0–9) [0–2] 4 (0–8) [0–4] n number, SD Standard deviation, IQR Interquartile range [25–75] *Polypharmacy was defined as using ≥ 5 medications **Weight loss was defined as ≥ 10% loss of total body weight in the past six months ***ADLs Activities of Daily Living, IADLs The Instrumental Activities of Daily Living, S-MMSE Standardized Mini Mental State Examination, GDS Geriatric depression scale, MNA-SF Mini Nutritional Assessment-Short Form, SARC-F The Strength, Assistance in walking, Rise from a chair, Climb stairs, Falls Table 3Correlation table the Makizako Social Frailty Index between comprehensive geriatric assessmentCorrelation in all patientsNumber of Medicationsr:−0.102p = 0.185ADLsr:−0,242p = 0,001IADLsr:−0,246p < 0,001S-MMSEr:−0,180p = 0,019MNA-SFr:−0,267p < 0,001SARC-Fr:0,342p < 0,001ADLs Activities of Daily Living, IADLs The Instrumental Activities of Daily Living, S-MMSE Standardized Mini Mental State Examination, MNA-SF Mini Nutritional Assessment-Short Form, SARC-F The Strength, Assistance in walking, Rise from a chair, Climb stairs, Falls Correlation table the Makizako Social Frailty Index between comprehensive geriatric assessment r:−0.102 p = 0.185 r:−0,242 p = 0,001 r:−0,246 p < 0,001 r:−0,180 p = 0,019 r:−0,267 p < 0,001 r:0,342 p < 0,001 ADLs Activities of Daily Living, IADLs The Instrumental Activities of Daily Living, S-MMSE Standardized Mini Mental State Examination, MNA-SF Mini Nutritional Assessment-Short Form, SARC-F The Strength, Assistance in walking, Rise from a chair, Climb stairs, Falls Table 4The Makizako Social Frailty Index and reference test concordance resultsMakizako Social Frailty IndexKappapRobust/PrefrailLiving with Social FrailtyEdmonton Frailty Scale0.287< 0.001Robust/Prefrail108 (93.1%)37 (68.5%)Living with Frailty8 (6.9%)17 (31.5%)Inter-rater reliability--0.913< 0.001Re-test reliability--0.895< 0.001 The Makizako Social Frailty Index and reference test concordance results A moderate level of agreement between the Makizako Social Frailty Index and the EFS (Cohen's kappa: 0.287, p<0.001) was observed. In addition, the Makizako Social Frailty Index exhibited exceptional inter-rater and retest reliabilities. This outcome reflects the high level of consistency and accuracy in the assessment process, which is critical in ensuring reliable and valid results (Cohen's kappa: 0.913, p<0.001 and 0.895, p<0.001, respectively). The sensitivity of the Makizako Social Frailty Index, when assessed against the reference scale, was found to be 68.00% (95%CI: 46.50–85.05), with a corresponding specificity of 74.48% (95%CI: 66.58–81.35). The positive predictive value was determined to be 31.48% (95%CI: 23.78–40.35), and the negative predictive value was 93.10% (95%CI: 88.32–96.02). Regarding likelihood ratios, the positive likelihood ratio was calculated as 2.66 (95%CI: 1.81–3.92), while the negative likelihood ratio was 0.43 (95%CI: 0.24–0.77). Discussion This study was conducted to establish the validity and reliability of the Makizako Social Frailty Index among Turkish older adults. To the best of our knowledge, no Turkish version of a social frailty scale exists for validation. Although the EFS is a multidimensional scale encompassing the social components of frailty, the Makizako Social Frailty Index, despite being solely focused on social frailty, exhibited a meaningful correlation with it. Also, the high level of accuracy in predicting negative outcomes of our study demonstrates the index's effectiveness in ruling out the presence of living with social frailty when the result is negative. A comprehensive review determined that the prevalence of frailty among older adults residing in the community was 10.7% [17]. According to a study, the overall estimated prevalence of frailty was 17% [18]. In our study population, we identified a frailty prevalence of 14.7% according to the EFS, which was similar to the literature. According to the Makizako Social Frailty Index, we determined a living with social frailty rate of 31.8%. Previous studies based on the Makizako Social Frailty Index indicate that the social frailty rate among older adults living in the community ranges from 3.6% to 48.4% [19–21]. The prevalence of social frailty can vary significantly across countries, owing to factors such as differences in social structures, cultures, and economics. Furthermore, differences in study methodologies, including cross-sectional and cohort studies, can also contribute to this variance, as these studies often have different inclusion and exclusion criteria. It is crucial to consider these variables when studying living with social frailty to ensure that the results are accurate and unbiased. In EFS, social vulnerability is assessed regarding social support with just one question. However, the Makizako Social Frailty Index version comprehensively evaluates individuals from a broader perspective regarding social vulnerability. It queries whether the individual goes out less compared to the previous one. It assesses how much an individual participates in social activities by sometimes asking whether they visit their friends and talk to someone daily. It is questioned whether individuals live alone. Studies have shown that the probability of living alone, leading to social vulnerability, is higher than living with a partner or relatives [5], emphasizing the importance of this question. The question"Do you feel you are helpful to friends or family?" in the Makizako Social Frailty Index is essential for patients to assess themselves. The fact that the Makizako Social Frailty Index evaluates social frailty from a broad perspective underscores the importance of ensuring its validity in Turkish. Additionally, it demonstrates a favorable level of specificity. As a result, this study has confirmed the validity and reliability of the Makizako Social Frailty Index as a social frailty screening tool for the older population in Türkiye. The comprehensive assessment of frailty, encompassing its physical, cognitive, psychological, and social components, is crucial for a broad perspective in patient care. A constant loss of activity, resources, or the capacity to engage in social activities to meet fundamental social requirements was referred to as social frailty [4]. A review study has revealed that the prevalence of frailty among older adults residing in the community is 10.7% [17]. If we examine the prevalence of one of the three components of frailty, which is social frailty, in a meta-analysis conducted in 2023 on the prevalence of older adults living with social frailty, it was demonstrated that the pooled prevalence of social frailty was 23.9% (95% CI: 19.9%−27.9%) Additionally, statistically significant differences in social frailty prevalence by country were found. Among community-dwelling older adults, the prevalence of living with social frailty was lowest in China (4.9%), followed by Spain (11.6%), Japan (16.2%), Korea (26.6%), and the Netherlands (27.2%) [5]. No study has been conducted on the prevalence of social frailty in Türkiye. Social frailty can lead to significant outcomes, such as a reduction in an individual's capacity for self-care, higher occurrences of depression in older adults, and an increased likelihood of mortality [5]. Therefore, the assessment of social frailty holds great significance. Studies have shown a connection between frailty, advanced age, and low education level [22]. In line with expectations, we found that the mean age of people living with social frailty was greater than that of living with robust/prefrail individuals. Those with an educational level of five years or less were observed more frequently in older adults living with social frailty. However, it was not statistically significant. Furthermore, consistent with previous research, there was a greater incidence of female gender among those who lived with social frailty. In our study, 66.67% of patients living with social frailty were female. Research indicates that older female adults are more prone to living with social frailty compared to older male adults [23, 24]. The difference in gender may be due to the fact that women tend to live longer, are more likely to live by themselves, and are more susceptible to psychological factors like depression, anxiety, and loneliness [25]. It seems that women were more likely than males to live with social frailty [26]. The high proportion of female participants could be of interest to future studies, particularly when considering potential gender differences in social frailty. Consequently, women might be more prone to social frailty [4]. Another noteworthy finding is that when comparing married individuals to those who were single, divorced, or widowed individuals, the robust/prefrail ratios were higher than those observed in individuals living with social frailty. Recently, in a study conducted by B. Bassa et al. with 193 patients, similar to our research, lower levels of social frailty were observed in married individuals [27]. Moreover, living alone was considered one of the significant factors contributing to social frailty [28]. Our study identified a living alone percentage of 18.8% in the general population. Additionally, we observed rates of 33.3% in the living with social frailty group and 12.1% in the robust/prefrail group, and this difference was statistically significant. The relationship between living alone and social frailty has been demonstrated in previous studies [29, 30]. In our study, type 2 diabetes mellitus, hypertension, asthma, and chronic obstructive pulmonary disease were observed at higher frequencies in patients living with social frailty. Although the rates of hyperlipidemia and coronary artery disease were similar between individuals living with social frailty and those who were living with social robust or prefrailty, they still contributed to an increased disease burden in the living with social frailty group. Importantly, only asthma showed a statistically significant difference between living with social frailty and living with social robust/prefrailty groups. It should be clarified that, unlike physical frailty, there is currently no substantial evidence examining the relationship between living with social frailty and chronic diseases. Additionally, while urinary incontinence and falls were more common in the living with frail group, only urinary incontinence reached statistical significance compared to the living with robust/prefrailty groups, with no significant difference observed for falls. Similar to chronic diseases, the association between living with social frailty and conditions like falls or urinary incontinence has yet to be adequately explored in the literature. Even though it was not statistically significant, polypharmacy was observed at higher percentages in individuals living with frailty. However, there was a notable distinction between the two groups when the number of medications was considered. When comparing the median and IQR values of the number of medications between the living with social robust/prefrailty and living with frailty groups, consistent polypharmacy was consistently higher in the living with frailty group. Further research is needed in the fields of polypharmacy and social frailty. Another significant point was the higher percentage of involuntary weight loss in the living with frailty group over the past six months. However, the statistical comparison between the two groups yielded insignificant results. This may be a potential risk factor for malnutrition in this group. Moreover, due to potential associations with malignancy, depression, and inability to access food, there is a need for studies with a more significant number of participants in this field. In contrast to previous research [7], we have found that the living with socially robust/prefrail group exhibited higher rates of dementia and depression when compared to the living with social frailty group. We considered that this may be attributed to the socio-cultural structure of our country. It should be noted that the question 'Do you feel you are helpful to friends or family?' in the Makizako Social Frailty Index requires insight. As such, patients with moderate and advanced-stage dementia were excluded from the criteria. Moreover, participants with the inability to provide a history, inability to cooperate, moderate to severe dementia, and major depression were excluded from the study. Therefore, the prevalence of dementia and depression might be underestimated in the living with social frailty group. Recent studies have shown that social frailty is associated with limitations in activities of daily living (ADLs) and an increased risk of disability in older adults [31, 32]. Social frailty, regardless of physical frailty, is linked to a higher likelihood of experiencing functional and severe disabilities in older adults [33]. In our study, we observed a significant difference in ADLs and IADLs between patients living with social frailty and living with robust/prefraily. Additionally, we identified a correlation, though it was weak. We believe the low correlation may be attributed to the sample size. Further research is needed in this field to understand these associations better. In our study, a significant difference was found when the S-MMSE results of living with social frailty and living with robust/prefrailty patients were compared. While physical impairment is the primary characteristic of frailty, evidence indicates that other dimensions, including psychological, cognitive, and social factors, also play a role in this complex condition [34]. Social frailty impacts both the degree of social interaction and the ability to acquire resources needed for the daily lives of older adults [35]. In 2020, C Lee et al. examined the relationship between the Mini-Nutritional Assessment (MNA) and social frailty in a study involving a total of 2,552 community-dwelling older adults aged 70–84 years (mean age 76.9±4.0) [35]. In our study, we utilized the MNA-SF, which demonstrated a high level of concordance with the full MNA [36], to screen patients for malnutrition. When living with social frailty and living with robust/prefrailty patients were compared with MNA-SF, we found a significant difference between the two groups, consistent with the literature. We also found a negative correlation between the Makizako Social Frailty Index and MNA-SF. This shows that as social frailty increases, the risk of malnutrition also increases. We recommend that socially frail individuals are at higher risk of malnutrition and practitioners should take this into consideration when evaluating patients. This study had some limitations. The Makizako Social Frailty Index is a self-reported questionnaire comprising five items that assess social frailty in older adults. Because of that, exclusion criteria were determined meticulously to ensure that self-reported questions could be answered correctly. This may be among the study's limitations in terms of the prevalence of living with social frailty. More studies are needed in the future to obtain more data in this area. (Reviewer 1 Answer 3, 14). Another limitation is that there is no Turkish social frailty measure to validate and rehabilitate The Makizako Social Frailty Index. The validity and reliability of such a tool in Turkish would be necessary because social frailty is an essential component of frailty. We preferred the EFS because it is multidimensional and includes the social frailty component. We looked at the general correlation because living with social frailty is assessed with only one question in the EFS and because living with social frailty is closely related to other frailty components. (Reviewer 1 Answer 9). Another limitation is that in geriatric practice, 5% weight loss within 6 months or a year is more commonly used than 10%. Since our study was designed to only provide 10% weight loss within the last 6 months or a year during the data collection phase, we could not perform analysis with 5% loss. In future studies, additional analyses can be planned by including data on 5% weight loss within 6 months or a year. In addition, we found a significant difference between the two groups living with social frailty or not with SARC-F, which is widely used in sarcopenia screening [37]. In the correlation analysis, we found that as The Makizako Social Frailty Index score increases, i.e., as social frailty increases, the SARC-F score, i.e., the risk of sarcopenia, increases. No study shows the relationship between sarcopenia and social frailty that we know of. New studies are needed in this field in the future. Consequently, this research has substantiated the validity and reliability of the Makizako Social Frailty Index for Turkish older adults. Utilizing the Makizako Social Frailty Index, alongside the assessment of physical frailty within the older adult patients cohort, can potentially ameliorate negative health repercussions linked to social frailty. Acknowledgements Not applicable. Authors’ contributions The conception and design of the study: CA, CB, MC. Acquisition of data, or analysis and interpretation of data: HS, DK, ZŞ, MH, MP. Drafting the article: CA, CB, MC. Final approval of the version to be submitted: CA, BBD, MH, MC, CB. Funding No funding was received for this study Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.